Resources VIDEOS 02:02 Patients that may benefit from addition of an ICS 02:17 ICS usage and eosinophil count as biomarker in COPD patients 08:30 Gold Update 2019: Prof. Vogelmeier 02:52 COPD Video 06:20 Benefits of ARBs in the Treatment of Hypertension 06:52 Prof Ryner: Controversies in Hypertension 01:01 38% relative risk reduction in CV death with Jardiance 0:58 CV Reduction was generally consistent across baseline HbA1c 0:59 Patients could live longer with Jardiance 01:01 Relative risk reduction of CV death by more than 1/3 01:01 Early impact on risk reduction of CV death 01:01 32% Relative risk reduction in all-cause mortality 01:03 Reduction of CV death was achieved ontop of standard of care 01:01 35% Relative reduction in hospitilization for heart failure 01:24 Actilyse Reconstitution Video 01:24 Mode of Action Video 21:08 DR DUIM: ACUTE STROKE MANAGEMENT 03:36 Dr. Todd C.Villines: Pradaxa vs other NOACs 00:32 Life happens: Car accidents 00:49 Life happens: How emergency situations affect life of patients on OAC treatment 00:42 Life happens: Appendicitis is one of the most frequent abdominal surgical emergencies 01:29 Idarucizumab (Praxbind®) patient case in gallbladder removal 03:00 Idarucizumab (Praxbind®) real patient cases 06:12 Reversibility of NOAC therapies: the neurologist's perspective 01:18 Dosage & Administration 02:03 Praxbind Administration 01:01 Mode of Action Video 02:53 Mode of Action Video 05:36 Thrive Summit Overview 31:27 Dr. Bhana – TDM: Current Treatment Therapies 03:16 NOACS What The Past 5 Years Taught Us 01:17 BID vs Once Daily Dosing 06:52 NOAC safety in clinical practice: Evidence from the real world 02:52 GLORIA-AF Info Graphic video 02:58 Pradaxa Real Patient Cases 03:50 From Clinical Trials To RWE info Graphic Video Load more Clinical studies WISDOM Trial UPLIFT Clinical Trial Summary COPD Treatment: GOLD Guidelines Infographic Spiriva Exacerbation Data vs Anoro Spiriva vs Salmeterol: Time to first excacerbation Spiriva vs Salmeterol: Severe Excacerbation data COPD Symptom Checker Surgical Intervention Indication and Dosage Risk vs Benefit Precautions When Using Actilyse Minimising the Risk of Bleeding Monitoring for Major and Minor Bleeding Risk Factors for ICH Bleed Management Overview AHA/ASA Recommendations for Managing sICH AHA/ASA: Reversal Agents Contra-indications Telmisartan unique attributes 24 Hour BP Control Cardio Metabolic Patients ONTARGET trial Telmisartan unique attributes 24 Hour BP Control Cardio Metabolic Patients Guidelines for the management of Acute Ischaemic Stroke Endovascular Therapy Actilyse Stroke - Act FAST The increasing burden of stroke The importance of treating stroke as an emergency Early treatment of stroke is great benefit to your patient Clinical presentation, diagnosis, and management of pulmonary embolism Atrial fibrillation and stroke An overview of Atrial Fibrillation (AF) Stroke prevention in Atrial Fibrillation (AF) Mechanisms of anticoagulation Managament of deep vein thrombosis Efficacy Reimbursement Information Dosage Mechanism of Action Pradaxa:Mechanism of Action RE-DUAL PCI Safety & Tolerability Load more BI LEARNING Ethics: Distributive Justice Ethics: Professionalism Ethics Hypertension 1 Hypertension 2 Load more